- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/00 - Peptides having up to four amino acids in a fully defined sequenceDerivatives thereof
Patent holdings for IPC class C07K 5/00
Total number of patents in this class: 931
10-year publication summary
|
65
|
58
|
53
|
35
|
38
|
18
|
20
|
14
|
7
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20745 |
22 |
| Protagonist Therapeutics, Inc. | 154 |
10 |
| Centre National de La Recherche Scientifique | 11023 |
9 |
| Massachusetts Institute of Technology | 10251 |
8 |
| Northwestern University | 3543 |
8 |
| The University of British Columbia | 1538 |
8 |
| Bicyclerd Limited | 155 |
8 |
| Novartis AG | 10262 |
7 |
| The Johns Hopkins University | 5882 |
7 |
| Arrowhead Pharmaceuticals, Inc. | 347 |
7 |
| Onyx Therapeutics, Inc. | 66 |
7 |
| Wisconsin Alumni Research Foundation | 3898 |
6 |
| The General Hospital Corporation | 4870 |
6 |
| Adocia | 145 |
6 |
| Emulate, Inc. | 190 |
6 |
| President and Fellows of Harvard College | 6094 |
5 |
| Purdue Research Foundation | 3916 |
5 |
| Academia Sinica | 958 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2664 |
5 |
| Hangzhou DAC Biotech Co., Ltd | 113 |
5 |
| Other owners | 781 |